Related references
Note: Only part of the references are listed.The regulation of AMPK β1, TSC2, and PTEN expression by p53:: Stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways
Zhaohui Feng et al.
CANCER RESEARCH (2007)
Aerosol delivery of Akt controls protein translation in the lungs of dual luciferase reporter mice
A. M. Tehrani et al.
GENE THERAPY (2007)
Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice
H Jin et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
JM Tang et al.
LUNG CANCER (2006)
PTEN enters the nucleus by diffusion
FH Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers
MR Park et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Modified polyethylenimines as non viral gene delivery systems for aerosol therapy:: effects of nebulization on cellular uptake and transfection efficiency
LA Dailey et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Evidence for cyclin D3 as a novel target of rapamycin in human T lymphocytes
M Hleb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
mTOR: a protein kinase switching between life and death
L Asnaghi et al.
PHARMACOLOGICAL RESEARCH (2004)
K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation - Possible contribution to non-invasive expansion of lung adenocarcinoma
K Okudela et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E
DC Fingar et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice
HW Kim et al.
CANCER RESEARCH (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Efficient gene delivery by urocanic acid-modified chitosan
TH Kim et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Phosphorylation site interdependence of human p53 post-translational modifications in response to stress
S Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms
DJ Freeman et al.
CANCER CELL (2003)
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
S Ferrari et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
PTEN function in mammalian cell size regulation
SA Backman et al.
CURRENT OPINION IN NEUROBIOLOGY (2002)
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
T Merdan et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network
LD Mayo et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
L Johnson et al.
NATURE (2001)
Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes
A Gautam et al.
MOLECULAR THERAPY (2001)
TOR, a central controller of cell growth
T Schmelzle et al.
CELL (2000)
Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes
D Goula et al.
GENE THERAPY (2000)
Share Paper
